BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29747748)

  • 21. Rapamycin Ameliorates Experimental Autoimmune Encephalomyelitis by Suppressing the mTOR-STAT3 Pathway.
    Hou H; Miao J; Cao R; Han M; Sun Y; Liu X; Guo L
    Neurochem Res; 2017 Oct; 42(10):2831-2840. PubMed ID: 28600752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CC chemokine receptor 5 antagonist alleviates inflammation by regulating IFN-γ/IL-10 and STAT4/Smad3 signaling in a mouse model of autoimmune encephalomyelitis.
    Ahmad SF; Nadeem A; Ansari MA; Bakheet SA; Shahid M; Al-Mazroua HA; As Sobeai HM; Alasmari AF; Alanazi MM; Alhamed AS; Aldossari AA; Attia SM
    Cell Immunol; 2022 Sep; 379():104580. PubMed ID: 35872534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cathepsin B inhibitor alleviates Th1, Th17, and Th22 transcription factor signaling dysregulation in experimental autoimmune encephalomyelitis.
    Ansari MA; Nadeem A; Alshammari MA; Attia SM; Bakheet SA; Khan MR; Albekairi TH; Alasmari AF; Alhosaini K; Alqahtani F; Al-Mazroua HA; Ahmad SF
    Exp Neurol; 2022 May; 351():113997. PubMed ID: 35122866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z; Haghmorad D; Sankian M; Rastin M; Nosratabadi R; Soltan Dallal MM; Tabasi N; Khazaee M; Nasiraii LR; Mahmoudi M
    Biomed Pharmacother; 2017 Nov; 95():1535-1548. PubMed ID: 28946394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amelioration of experimental autoimmune encephalomyelitis by curcumin treatment through inhibition of IL-17 production.
    Xie L; Li XK; Funeshima-Fuji N; Kimura H; Matsumoto Y; Isaka Y; Takahara S
    Int Immunopharmacol; 2009 May; 9(5):575-81. PubMed ID: 19539560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NFATc1 deficiency in T cells protects mice from experimental autoimmune encephalomyelitis.
    Reppert S; Zinser E; Holzinger C; Sandrock L; Koch S; Finotto S
    Eur J Immunol; 2015 May; 45(5):1426-40. PubMed ID: 25689841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
    Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
    Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rapamycin relieves inflammation of experimental autoimmune encephalomyelitis by altering the balance of Treg/Th17 in a mouse model.
    Li Z; Nie L; Chen L; Sun Y; Li G
    Neurosci Lett; 2019 Jul; 705():39-45. PubMed ID: 31004709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1.
    Brunsing RL; Prossnitz ER
    Immunology; 2011 Sep; 134(1):93-106. PubMed ID: 21722102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
    Yang C; He D; Yin C; Tan J
    Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Small molecules targeting RORγt inhibit autoimmune disease by suppressing Th17 cell differentiation.
    Tan J; Liu H; Huang M; Li N; Tang S; Meng J; Tang S; Zhou H; Kijlstra A; Yang P; Hou S
    Cell Death Dis; 2020 Aug; 11(8):697. PubMed ID: 32829384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DAB
    Bhopale MK; Hilliard B; Constantinescu CS; Phillips SM; Rostami A
    Immunopharmacol Immunotoxicol; 2017 Dec; 39(6):318-329. PubMed ID: 28929835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.
    Hwang I; Ahn G; Park E; Ha D; Song JY; Jee Y
    Immunol Lett; 2011 Aug; 138(2):169-78. PubMed ID: 21524666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCDC134 ameliorated experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
    Xia P; Gong X; Xiao L; Wang Y; Zhang T; Liao Q; Mo X; Qiu X; Huang J
    Brain Behav Immun; 2018 Jul; 71():158-168. PubMed ID: 29548993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absence of Notch1 in murine myeloid cells attenuates the development of experimental autoimmune encephalomyelitis by affecting Th1 and Th17 priming.
    Fernández M; Monsalve EM; López-López S; Ruiz-García A; Mellado S; Caminos E; García-Ramírez JJ; Laborda J; Tranque P; Díaz-Guerra MJM
    Eur J Immunol; 2017 Dec; 47(12):2090-2100. PubMed ID: 28762472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silencing c-Rel in macrophages dampens Th1 and Th17 immune responses and alleviates experimental autoimmune encephalomyelitis in mice.
    Zhang H; Bi J; Yi H; Fan T; Ruan Q; Cai L; Chen YH; Wan X
    Immunol Cell Biol; 2017 Aug; 95(7):593-600. PubMed ID: 28202908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procyanidin B2 gallates inhibit IFN-γ and IL-17 production in T cells by suppressing T-bet and RORγt expression.
    Tanaka S; Furuya K; Yamamoto K; Yamada K; Ichikawa M; Suda M; Makabe H
    Int Immunopharmacol; 2017 Mar; 44():87-96. PubMed ID: 28088699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of human and mouse Th17 differentiation and autoimmunity by an endogenous Interleukin 23 receptor cytokine-binding homology region.
    Guo W; Luo C; Wang C; Wang YH; Wang X; Gao XD; Yao WB
    Int J Biochem Cell Biol; 2014 Oct; 55():304-10. PubMed ID: 25263529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The histone H3 lysine-27 demethylase Jmjd3 plays a critical role in specific regulation of Th17 cell differentiation.
    Liu Z; Cao W; Xu L; Chen X; Zhan Y; Yang Q; Liu S; Chen P; Jiang Y; Sun X; Tao Y; Hu Y; Li C; Wang Q; Wang Y; Chen CD; Shi Y; Zhang X
    J Mol Cell Biol; 2015 Dec; 7(6):505-16. PubMed ID: 25840993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
    Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
    Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.